PPT-Ovarian cancer with update from ASCO 2013

Siew wei wong Oncology registrar Epidemiology 225000 new incidence annually worldwide Incidence stable since 1970s 1600 new cases in Australia in 2010 Median age at diagnosis 63 Fourth commonest cause of cancer death in women in developed countries. Arkansas Statistics. Nancy Andrews Collins, M.D., MBA. Associate Professor. Department of Obstetrics and Gynecology. College of Medicine. University of Arkansas for Medical Sciences (UAMS). Ovarian Cancer. . Highlights from the Annual Clinical Meeting. Gynecologic Cancer. Sidney A. Scudder, MD. Professor of Medicine. U.C. Davis Cancer Center. Conference Directors:. Helen Chew, MD, FACP. Primo Lara, Jr., MD. Clinical Practice Guideline Update. American Society of Clinical Oncology /. College of American Pathologists . www.asco.org/guidelines/. © American . Society of Clinical Oncology®.  All rights reserved.. Ovarian Cancer. Epithelial Tumor, . postmenopausal women. Germ cell,. younger women. Sex cord-stromal origin,. any age. Approximately 90% of ovarian cancer is epithelial . significant . therapeutic challenges . Quang Truong. 02-13-13. Mr. . Kashub. . 2. nd. Session. What is Ovarian Cancer?. Ovarian cancer is a cancerous growth arising from the ovary. .. The “silent killer”. . What are the types of ovarian cancer you may have?. Presented By Olivia Pagani at 2014 ASCO Annual Meeting. TEXT and SOFT. Presented By Olivia Pagani at 2014 ASCO Annual Meeting. TEXT and SOFT Worldwide Collaborative. Presented By Olivia Pagani at 2014 ASCO Annual Meeting. Diagnostic work-up. Treatment. The most commonly occurring gynecologic cancer is:. Cervical. Endometrial. Ovarian. Vulvar. The gynecologic cancer with the highest death rate is:. Cervical. Endometrial. Improvement in 5 Year Survival:. Race. 1975. 1989. 2014. All. 36%. 38%. 47%. White. 35%. 38%. 48%. African American. 42%. 34%. 39%. Noone. AM, . Howlader. N, . Krapcho. M, et al. (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute, Bethesda, MD, www.seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.. Lisa McCluskey, MD. Gynecologic Oncologist. June 16, 2015. Compass Oncology . in partnership with . Ovarian . Cancer Alliance of Oregon & SW . Washington. What. is Ovarian Cancer. ?. The most common type of Ovarian Cancer that starts from . Christopher Morse, MD. Fellow, Gynecologic oncology. UW MEDICINE. CONFIDENTIAL – DO NOT DISTRIBUTE. Overview. Introduction to ovarian cancer. Diagnosis and treatment. Surgery and chemotherapy. Surveillance. SH-Sheikh . hasani. GYN.Oncologist. Imamkhomeini. Hospital. Prevalence of Ovarian Cancer. the most lethal . gynaecological. tumor . . prevalence. : . 3.7. %. of all female cancers and for 4.2% of . . Henny Lukman. Consultant Obstetrician & Gynaecologist. Cancer. General Population Risk. Syndrome Risk. Mean age of onset. 10 year survival (England & Wales). Endometrium. 3%. 40-60%. 48-55. 1 The Facts Ovarian cancer is the fourth most common cancer in women. Each year about 400 women are diagnosed with ovarian cancer in Ireland. The symptoms can be very vague, particularly when the d introduction. S. econd most common gynecologic malignancy.. I. n . developed countries, . the incidence . of 9.4 per 100,000 women and a mortality rate of 5.1 per 100,000.. In developing countries, it is the third most common gynecologic malignancy (cervical cancer is the most common), with an incidence of 5.0 per 100,000 and a mortality rate of 3.1 per 100,000. .